ONCO
Income statement / Annual
Last year (2024), Onconetix, Inc.'s total revenue was $2.52 M,
an increase of 4,217.31% from the previous year.
In 2024, Onconetix, Inc.'s net income was -$58.69 M.
See Onconetix, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.52 M |
$58.47 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.47 M
|
$1.19 M
|
$6.75 K
|
$4.89 K
|
$3.06 K
|
$573.00
|
| Gross Profit |
$1.06 M
|
-$1.13 M
|
-$6.75 K
|
-$4.89 K
|
-$3.06 K
|
-$573.00
|
| Gross Profit Ratio |
0.42
|
-19.28
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$154.36 K
|
$1.95 M
|
$4.13 M
|
$1.33 M
|
$524.91 K
|
$60.17 K
|
| General & Administrative Expenses |
$11.23 M
|
$14.77 M
|
$9.35 M
|
$2.09 M
|
$1.10 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.23 M
|
$14.77 M
|
$9.35 M
|
$2.09 M
|
$1.10 M
|
$819.49 K
|
| Other Expenses |
$46.16 M
|
$18.19 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$57.54 M
|
$34.91 M
|
$13.48 M
|
$3.42 M
|
$1.62 M
|
$879.66 K
|
| Cost And Expenses |
$59.01 M
|
$36.09 M
|
$13.48 M
|
$3.42 M
|
$1.62 M
|
$880.23 K
|
| Interest Income |
$18.00
|
$0.00
|
$0.00
|
$0.00
|
$22.60 K
|
$58.32 K
|
| Interest Expense |
$1.41 M
|
$671.63 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$731.35 K
|
$43.94 K
|
$6.75 K
|
$4.89 K
|
$3.06 K
|
$573.00
|
| EBITDA |
-$57.60 M |
-$36.71 M |
-$13.41 M |
-$3.41 M |
-$1.60 M |
-$821.34 K |
| EBITDA Ratio |
-22.82
|
-627.84
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-22.38
|
-616.34
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$3.25 M
|
-$1.39 M
|
$61.41 K
|
$0.00
|
$22.60 K
|
$58.32 K
|
| Income Before Tax |
-$59.74 M
|
-$37.42 M
|
-$13.42 M
|
-$3.42 M
|
-$1.60 M
|
-$821.92 K
|
| Income Before Tax Ratio |
-23.67
|
-640.08
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.05 M
|
-$12.59 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$58.69 M
|
-$37.41 M
|
-$13.42 M
|
-$3.42 M
|
-$1.60 M
|
-$821.92 K
|
| Net Income Ratio |
-23.25
|
-639.86
|
0
|
0
|
0
|
0
|
| EPS |
-1823.25 |
-87.6 |
-1.09 |
-0.31 |
-0.14 |
-0.0744 |
| EPS Diluted |
-1823.25 |
-87.6 |
-1.09 |
-0.31 |
-0.14 |
-0.0744 |
| Weighted Average Shares Out |
$32.30 K
|
$427.78 K
|
$12.27 M
|
$10.91 M
|
$11.05 M
|
$11.05 M
|
| Weighted Average Shares Out Diluted |
$32.30 K
|
$427.78 K
|
$12.27 M
|
$10.91 M
|
$11.05 M
|
$11.05 M
|
| Link |
|
|
|
|
|
|
